F. Indrio

University of Bari Aldo Moro

Health Outcomes Studied

• Reduced Colitis-Related Mortality

Papers (4)

• 2022
  Use of Limosilactobacillus reuteri DSM 17938 in paediatric gastrointestinal disorders: an updated review.10.3920/BM2021.0151
• 2019
  Lactobacillus reuteri DSM 17938 Improves Feeding Intolerance in Preterm Infants10.5223/pghn.2019.22.6.545
• 2018
  Lactobacillus reuteri to Treat Infant Colic: A Meta-analysis10.1542/peds.2017-1811
• 2014
  The early administration of Lactobacillus reuteri DSM 17938 controls regurgitation episodes in full-term breastfed infants10.3109/09637486.2014.898251